COVID-19 has made pregnancy and childbirth incredibly difficult to navigate, both physically and emotionally. As a result, it has been essential to transition integrated behavioral health services to a virtual format as quickly as possible.

We had, prior to COVID-19, started moving toward offering a virtual service option to reduce barriers to care. But the movement was slow because the necessary framework didn’t yet exist, including with regard to standards of care, billing practices and coverage. While these barriers are tangible, the “forced transition” to virtual care has unexpectedly served to uncover a less obvious barrier … our own preconceived notions about with whom, and under what circumstances, technology can be useful to facilitate behavioral health care, especially with pregnant and postpartum women.

In short, it has been humbling to contrast prior assumptions with our new experiences; a colleague and licensed clinical social worker, Sarah Rasche, notes her surprise about how efficiently a virtual visit can provide a snapshot of a patient’s reality, which she believes has contributed to more efficient rapport building and therapeutic solidarity. Additionally, while it is anecdotal at this time, the rate of “no shows” to virtual behavioral health visits has been almost non-existent … another piece of important information as we continually problem solve staffing and program sustainability.

During this unprecedented time, we encourage other maternal and behavioral health programs to consider the positives of switching to virtual care. For more information on behavioral health, visit AHA’s COVID-19 Stress and Coping Resources page.

Keri Hanson is a licensed clinical social worker and maternal mental health program coordinator at SCL Health/Saint Joseph Hospital in Denver, Colo.

Related News Articles

Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
Lindsey Fauveau, M.D., medical director of breast surgical oncology at Woman’s Hospital, shares how the hospital’s state-of-the-art mobile unit brings 3D…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Perspective
Public
More than 48 million Americans — 16.8% of the 12-and-older population — have a substance use disorder (SUD), according to the 2025 National Survey on Drug Use…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…